06Feb/14

"Lavasa Women's Drive" set to drive into Guinness World Records – India PRwire (press release)

“Lavasa Women’s Drive” set to drive into Guinness World Records
India PRwire (press release)
It has also seen participation from the elite bollywood celebrities and many NGOs who support the causes like Save Water, Green India, Save the Tiger, Women’s issues, Organ donation and other social issues etc. Registrations and voting for LWD 2014 are 

06Feb/14

Changing meal times could affect liver – Times of India


Times of India

Changing meal times could affect liver
Times of India
In studying the role of circadian rhythm in the accumulation of lipids in the liver, postdoctoral fellow Yaarit Adamovich and the team in the lab of Dr. Gad Asher of the Weizmann Institute’s Biological Chemistry Department, together with scientists
Changing meal times could have significant effect on levels of triglycerides Zee News
Meal timings important for health of liverNewstrack India

all 11 news articles »

06Feb/14

Big Pharma pushes for US action against India on drugs – Livemint


Moneycontrol.com

Big Pharma pushes for US action against India on drugs
Livemint
In 2012, India issued its first ever compulsory licence to domestic drug maker Natco Pharma Ltd on a kidney and liver cancer drug, Nexavar, patented by Germany’s Bayer AG, in a move that it had said endangered pharmaceutical research. AstraZeneca Plc 
Big Pharma pushes for US action against India over patent worrieseuronews

all 12 news articles »

06Feb/14

EDITORIAL: Consider organ donation today to possibly save a life tomorrow – Monitor

EDITORIAL: Consider organ donation today to possibly save a life tomorrow
Monitor
In the Central and South Texas region — which includes 56 counties from Waco south to the Rio Grande Valley — 436 patients received life-saving organ transplants from 119 deceased donors, Segovia said. This is up from 2012, when 353 people received 
Agency sees increase in organ donationsValley morning Star

all 2 news articles »

05Feb/14

AbbVie Inc. Is Closer to Much-Needed Diversification, but Is It Enough? – DailyFinance

AbbVie Inc. Is Closer to Much-Needed Diversification, but Is It Enough?
DailyFinance
Other drugs like Elagolix and daclizumab also address meaningful potential markets, and AbbVie isn’t known for moving low-probability drugs into expensive late-stage tests. Even so, there are “buts” here – the success of Elagolix and daclizumab will

and more »